[1] Doi C, Egashira N, Kawabata A, et al. Angiotensin Ⅱ type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice[J]. BMC cancer, 2010, 10(1):67.
[2] PtasinskaWnuk D, Lawnicka H, Mucha S, et al. Angiotensins inhibit cell growth in GH3 lactosomatotroph pituitary tumor cell culture: a possible involvement of the p44/42 and p38 MAPK pathways[J]. Scient World J, 2012, 2012:189290.
[3] Arafat HA, Gong Q, Chipitsyna G, et al. Antihypertensives as novel antineoplastics: angiotensinIconverting enzyme inhibitors and angiotensin Ⅱ type 1 receptor blockers in pancreatic ductal adenocarcinoma[J]. J Am Coll Surg, 2007, 204(5):996-1005.
[4] Arrieta O, PinedaOlvera B, GuevaraSalazar P, et al. Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis[J]. Br J Cancer, 2008, 99(1):160-166.
[5] Shirotake S, Miyajima A, Kosaka T, et al. Angiotensin Ⅱ type 1 receptor expression and microvessel density in human bladder cancer[J]. Urology, 2011, 77(4):1009.
[6] DolleyHitze T, Jouan F, Martin B, et al. Angiotensin2 receptors (AT1R and AT2R), new prognostic factors for renal clearcell carcinoma?[J]. Br J Cancer, 2010, 103(11):1698-1705.
[7] Shirotake S, Miyajima A, Kosaka T, et al. Regulation of monocyte chemoattractant protein1 through angiotensin Ⅱ type 1 receptor in prostate cancer[J]. Am J Pathol, 2012, 180(3):1008-1016.
[8] Rcken C, Rhl FW, Diebler E, et al. The angiotensin Ⅱ/angiotensin Ⅱ receptor system correlates with nodal spread in intestinal type gastric cancer[J]. Cancer Epidemiol Biomarkers Prev, 2007, 16(6):1206-1212.
[9] CarlMcGrath S, Ebert MP, Lendeckel U, et al. Expression of the local angiotensin Ⅱ system in gastric cancer may facilitate lymphatic invasion and nodal spread[J]. Cancer Biol Ther, 2007, 6(8):1218-1226.
[10] Munn LL. Dynamics of tissue topology during cancer invasion and metastasis[J]. Phys Biol, 2013, 10(6):65003.
[11] Ino K, Shibata K, Yamamoto E, et al. Role of the reninangiotensin system in gynecologic cancers[J]. Curr Cancer Drug Tar, 2011, 11(4):405-411.
[12] Buharalioglu CK, Song CY, Yaghini FA, et al. Angiotensin Ⅱ induced process of angiogenesis is mediated by spleen tyrosine kinase via VEGF receptor1 phosphorylation[J]. Am J Physiol Heart Circ Physiol, 2011, 301(3):H1043-1055.
[13] Imai N, Hashimoto T, Kihara M, et al. Roles for host and tumor angiotensin Ⅱ type 1 receptor in tumor growth and tumorassociated angiogenesis[J]. Lab Invest, 2007, 87(2):189-198.
[14] Lau ST, Leung PS. Role of the RAS in pancreatic cancer[J]. Curr Cancer Drug Targets, 2011, 11(4):412-420.
[15] 王亮, 何裕隆, 张常华, 等. 血管紧张素转换酶抑制剂和血管紧张素Ⅱ受体拮抗剂抑制胃癌淋巴管生成的实验研究[J]. 消化肿瘤杂志(电子版), 2008, 1(1)34-39.
[16] Pickel L, Matsuzuka T, Doi C, et al. Overexpression of angiotensinⅡ type 2 receptor gene induces cell death in lung adenocarcinoma cells[J]. Cancer Biol Ther, 2010, 9(4):277-285.
[17] Louis SN, Chow L, Rezmann L, et al. Expression and function of ATIP/MTUS1 in human prostate cancer cell lines[J]. Prostate, 2010, 70(14):1563-1574.
[18] Clere N, Corre I, Faure S, et al. Deficiency or blockade of angiotensin Ⅱ type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis[J]. Int J Cancer, 2010, 127(10):2279-2291. |